Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lee SY et al. - Selective TAE is effective for tumor shrinkage in most renal angiomyolipomas, with acceptable complication and relapse rates. Tumor shrinkage occurring within 6 months after TAE may reflect the long-term effect of TAE.

Today in Hematology/Oncology...keeping you current

Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09

Renal cell carcinoma with caval involvement: Contemporary strategies of surgical treatment
Urologic Oncology: Seminars and Original Investigations, 12/18/09

Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells
Urologic Oncology: Seminars and Original Investigations, 12/18/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address